POZ July-August 2016

POZ July-August 2016

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:



The Re-invention Tour: Two of Madonna’s Blond Ambition dancers are long-term survivors shining the spotlight on HIV

Two of Madonna’s Blond Ambition dancers are long-term survivors now shining the spotlight on HIV.

Antiretrovirals: A Success Story—Celebrating 20 years of effective treatment

Celebrating 20 years of effective HIV treatment

The HIV Treatment Pipeline

“We need drugs that are gentler, kinder, better and cheaper.”

HIV by the Numbers

There are approximately 36.9 million people living with HIV worldwide

Facts and Fiction: A new novel by Tim Murphy explores the early years of the AIDS epidemic and imagines what lies in the future

A new novel explores the early years of the AIDS epidemic and imagines what lies in the future.

Milestones in the Era of Effective HIV Treatment

Here’s a timeline of the highlights.

2016 HIV Drug Chart

This quick-reference chart compares available medication options for HIV.

From the Editor

Oriol R. Gutierrez

Rescue Me

I admit to being a longtime Madonna fan.


Letters-July/August 2016

Feedback on the issue of gay men’s attraction to crystal meth and Bernie Sanders’s AIDS plan.


Positive Ends

The International AIDS Vaccine Initiative (IAVI) marks 20 years in the search for an end to the epidemic.

POZ Planet

Heroes Tour 2016

Doug Meyer makes sculptures of creative icons lost to AIDS.

Be a Quitter

This free online program helps HIV-positive smokers kick the habit.

Palm Springs HIV Profiles

The documentary Desert Migration spotlights 13 long-term survivors, all men, now living in Palm Springs, California.

Painting the Epidemic

The painter Hugh Steers died of AIDS-related illness at age 32 in 1995, a time when figurative painting like his was not in vogue.


My Sanctuary

Daniel Szymczyk, founder and CEO of The HIV League, shares why he started the nonprofit group and how running became a passion.

POZ Survey Says

fingers holding a test tube

Trial and Error

POZ recently asked whether you’ve ever participated in a clinical trial or would consider it. Here are your responses.

Research Notes

Prevention: Prison Proposal

Sending fewer men to prison and reducing sentences for those who are incarcerated could slow the spread of HIV.

Treatment: Hep C Horizons

Gilead Sciences’ HCV combo tablet regimen of Sovaldi and velpatasvir can be combined safely with most “boosted” antiretroviral treatment...

Cure: Suppressed Monkeys

An HIV cure drug from Gilead Sciences, GS-9620, has shown promise in rhesus macaque monkeys.

Concerns: Resistant Strains

People contracting HIV are increasingly acquiring strains that are resistant to antiretrovirals (ARVs).

Care and Treatment

A Much Healthier HIV Epidemic?

A new study suggests the HIV epidemic is actually in much better shape.

Media Jumps the HIV Cure Gun Yet Again

A slew of media outlets erroneously reported that scientists might be just three years away from developing a cure for HIV.

FDA OKs Gilead’s Descovy (Not for PrEP)

The U.S. Food and Drug Administration approved Gilead Sciences’ Descovy for the treatment of HIV in combination with other antiretrovirals.

Starting HIV Treatment May Improve Liver Health

Beginning antiretroviral treatment for HIV may provide a boost to liver health among those with and without hepatitis B or C viruses.

Early HIV Treatment Ups Quality of Life

Starting HIV treatment soon after diagnosis leads to modest improvements in quality of life compared with delaying treatment.

POZ Heroes

Together We Fight

Gregg Gonsalves first became involved in AIDS activism in the late 1980s, working with ACT UP Boston before moving to New York City.


Hot topics